Global Blood Therapeutics, Inc. Financials

Market Capitalization $4.62 Billion as of Oct. 1, 2022

Valuations Metrics as of Jan. 25, 2025

Trailing PE	9.70
Forward PE	14.61
Price to Sales TTM	C$0.72
Price to Book MRQ	C$0.89
Enterprise to Revenue	0.78
Enterprise to EBITDA	-6.21

Financial Reports as of Oct. 31, 2024

Financials

Fiscal Year Ends	2024-01-31
Most Recent Quarter	2024-10-31
Profit Margin	4.64%
Operating Margin	5.57%
Return on Assets TTM	-0.11%
Return on Equity TTM	5.61%

Income Statement

Revenue TTM	C$581,305,984
Revenue per Share TTM	C$17.80
Quarterly Revenue Growth	0.20%
Gross Profit TTM	C$224,457,000
EBITDA	C$4,610,000
Net Income to Common TTM	C$26,972,000
Diluted EPS TTM	C$1.34
Quarterly Earnings Growth YoY	478.80%

Balance Sheet

Total Cash MRQ	C$0
Total Cash per Share MRQ	C$0.00
Total Debt MRQ	C$
Total Debt to Equity MRQ	2.93
Current Ratio MRQ	1.09
Book Value per Share MRQ	C$14.59

Cash Flow

Operating Cash Flow TTM	C$280,000
Levered Free Cash Flow TTM	C$-17,466,124

GBT Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	32,390,300
Float Shares	10,506,379
Avg 10 Volume	1,890
Avg 30 Volume	None
Shares Short	1,582
Short Ratio	0.96
Short % of Shares	%
% Held by Insiders	67.01%
% Held by Institutions	12.05%

Stock Price Summary

Beta	0.62
Fifty Two Week Low	C$12.25
Fifty Two Week High	C$16.84
Fifty Two Week Change	12.30%
Day 50 MA	C$13.15
Day 200 MA	C$13.38

Dividends and Splits

Forward Annual Dividend Rate	C$0.36
Forward Annual Dividend Yield	2.50%
Trailing Annual Dividend Rate	C$0.36
Trailing Annual Dividend Yield	2.50%
Payout Ratio	43.37%
Dividend Date	2024-06-28
Ex Dividend Date	2024-06-21
Last Split Factor
Last Split Date	2010-04-01